The Manufacturers Life Insurance Company Buys New Holdings in Iqvia Holdings Inc (IQV)
The Manufacturers Life Insurance Company acquired a new stake in Iqvia Holdings Inc (NYSE:IQV) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 377,866 shares of the medical research company’s stock, valued at approximately $36,993,000. The Manufacturers Life Insurance Company owned about 0.18% of Iqvia at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Longview Partners Guernsey LTD acquired a new stake in shares of Iqvia during the fourth quarter worth $927,548,000. Jennison Associates LLC bought a new position in shares of Iqvia in the fourth quarter worth $80,421,000. WCM Investment Management CA bought a new position in shares of Iqvia in the fourth quarter worth $80,173,000. First Trust Advisors LP bought a new position in shares of Iqvia in the fourth quarter worth $74,421,000. Finally, Schwab Charles Investment Management Inc. bought a new position in shares of Iqvia in the fourth quarter worth $55,905,000. 92.34% of the stock is owned by institutional investors.
Iqvia Holdings Inc (NYSE:IQV) opened at $105.34 on Friday. The stock has a market capitalization of $21,910.00, a price-to-earnings ratio of 70.23, a price-to-earnings-growth ratio of 2.70 and a beta of 0.64. The company has a debt-to-equity ratio of 1.21, a current ratio of 1.19 and a quick ratio of 1.19. Iqvia Holdings Inc has a 12 month low of $76.80 and a 12 month high of $110.67.
In other news, Director Michael J. Evanisko sold 816 shares of the stock in a transaction dated Monday, March 5th. The stock was sold at an average price of $100.00, for a total transaction of $81,600.00. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider James H. Erlinger III sold 10,000 shares of the stock in a transaction dated Wednesday, January 17th. The shares were sold at an average price of $99.97, for a total value of $999,700.00. The disclosure for this sale can be found here. Insiders sold a total of 30,816 shares of company stock worth $3,093,400 over the last 90 days. Corporate insiders own 6.00% of the company’s stock.
A number of research analysts have issued reports on IQV shares. Evercore ISI started coverage on Iqvia in a research report on Thursday, January 18th. They issued an “outperform” rating and a $112.00 target price on the stock. Zacks Investment Research lowered Iqvia from a “hold” rating to a “sell” rating in a research note on Tuesday, February 20th. Mitsubishi UFJ Financial Group began coverage on Iqvia in a research note on Friday, December 15th. They set a “neutral” rating and a $112.00 price target on the stock. SunTrust Banks reissued a “hold” rating and set a $110.00 price target on shares of Iqvia in a research note on Monday, January 22nd. Finally, Piper Jaffray Companies reaffirmed a “hold” rating and issued a $103.00 price objective on shares of Iqvia in a research note on Thursday, February 15th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. Iqvia presently has an average rating of “Buy” and a consensus target price of $110.02.
Iqvia Company Profile
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.